Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review

Hormonal Treatment in Young People With Gender Dysphoria: A Systematic Review

(2018) Denise Chew et al.   PEDIATRICS

Estradiol for the mitigation of adverse effects of androgen deprivation therapy

(2017) Nicholas Russell et al.   ENDOCRINE-RELATED CANCER

Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline

(2017) Wylie C Hembree et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Development of Prostate Adenocarcinoma in a Transgender Male to Female Patient: Could Estrogen Therapy Have Played a Role?

(2017) Asma Sharif et al.   PROSTATE

Epidemiology of gender dysphoria and transgender identity

(2017) Kenneth J. Zucker   Sexual Health

Transient Elevated Serum Prolactin in Trans Women Is Caused by Cyproterone Acetate Treatment

(2017) Justine Defreyne et al.   LGBT Health

Prolactin levels during short- and long-term cross-sex hormone treatment: an observational study in transgender persons

(2016) N. M. Nota et al.   ANDROLOGIA

Meningiomas in three male-to-female transgender subjects using oestrogens/progestogens and review of the literature

(2016) P. V. ter Wengel et al.   ANDROLOGIA

Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation

(2016) Vinciane Corman et al.   ENDOCRINE-RELATED CANCER

Five new cases of breast cancer in transsexual persons

(2015) L. Gooren et al.   ANDROLOGIA

Breast Cancer in Male-to-Female Transgender Patients: A Case for Caution

(2015) Maryam Sattari   Clinical Breast Cancer

Cancer in the transgender community

(2015) Kevin R Loughlin   LANCET ONCOLOGY

A very rare case of breast cancer in a female-to-male transsexual

(2015) Yuko Katayama et al.   Breast Cancer

Breast Cancer in Male-to-Female Transsexuals: Use of Breast Imaging for Detection

(2014) Katharine D. Maglione et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Diagnosis of prolactinoma in two male-to-female transsexual subjects following high-dose cross-sex hormone therapy

(2014) F. S. Cunha et al.   ANDROLOGIA

Incidence of breast cancer in a cohort of 5,135 transgender veterans

(2014) George R. Brown et al.   BREAST CANCER RESEARCH AND TREATMENT

Expression of estrogen and progesterone receptors across human malignancies: new therapeutic opportunities

(2014) J. Munoz et al.   CANCER AND METASTASIS REVIEWS

Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens

(2013) L. Gooren et al.   ANDROLOGIA

Androgens and prostate cancer; pathogenesis and deprivation therapy

(2013) Mathis Grossmann et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy.

(2013) Rafal Turo et al.   CUAJ-Canadian Urological Association Journal

Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case–control study

(2013) K Wierckx et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Triple negative breast cancer in a male-to-female transsexual

(2013) S. T. Pattison et al.   INTERNAL MEDICINE JOURNAL

Breast Cancer Development in Transsexual Subjects Receiving Cross-Sex Hormone Treatment

(2013) Louis J. Gooren et al.   Journal of Sexual Medicine

Long‐Term Evaluation of Cross‐Sex Hormone Treatment in Transsexual Persons

(2012) Katrien Wierckx et al.   Journal of Sexual Medicine

Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy

(2012) Dejan V Nikolic et al.   World Journal of Surgical Oncology

Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual

(2012) Marina T. Bergoglio et al.   Endocrinologia y Nutricion

Hormonal therapies and meningioma: Is there a link?

(2011) Lucía Cea-Soriano et al.   Cancer Epidemiology

Breast Cancer in Female-to-Male Transsexuals: Two Cases With a Review of Physiology and Management

(2011) Theresa Shao et al.   Clinical Breast Cancer

A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones

(2011) Henk Asscheman et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient

(2010) Helene Cebula et al.   ACTA NEUROCHIRURGICA

Prolactinoma induced by estrogen and cyproterone acetate in a male-to-female transsexual

(2010) Katherine García-Malpartida et al.   FERTILITY AND STERILITY

Development of a symptomatic intracranial meningioma in a male-to-female transsexual after initiation of hormone therapy

(2010) Amy R. deIpolyi et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

(2010) Xiaohong R. Yang et al.   JNCI-Journal of the National Cancer Institute

Estimated Age- and Sex-Specific Incidence and Prevalence of Dopamine Agonist-Treated Hyperprolactinemia

(2009) M. Kars et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Examining Patient Conceptions: A Case of Metastatic Breast Cancer in an African American Male to Female Transgender Patient

(2009) Amar Dhand et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population

(2009) Michaël Grynberg et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones

(2008) Andreas Mueller et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies

(2008) Endogenous Hormones   JNCI-Journal of the National Cancer Institute